[Federal Register Volume 76, Number 34 (Friday, February 18, 2011)]
[Notices]
[Page 9587]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-3765]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Diabetes and Digestive and Kidney Diseases 
Diabetes Mellitus Interagency Coordinating Committee; Notice of Meeting

    The Diabetes Mellitus Interagency Coordinating Committee (DMICC) 
will hold a meeting on March 11, 2011, from 8:30 a.m. to 3:45 p.m. at 
the Bethesda Marriott Suites, 6711 Democracy Blvd., Bethesda, MD 20817. 
The meeting will be open to the public from 8:30 a.m. until 2 p.m.; the 
DMICC will meet in closed session from 2:10 p.m. until 3:45 p.m. 
Attendance is limited to space available. Non-Federal individuals 
planning to attend the meeting should notify the Contact Person listed 
on this notice at least 2 days prior to the meeting. Individuals who 
plan to attend and need special assistance, such as sign language 
interpretation or other reasonable accommodations, should inform the 
Contact Person listed below at least 10 days in advance of the meeting.
    The DMICC facilitates cooperation, communication, and collaboration 
on diabetes among government entities. DMICC meetings, held several 
times a year, provide an opportunity for members to learn about and 
discuss current and future diabetes programs in DMICC member 
organizations and to identify opportunities for collaboration. The 
March 11, 2011, DMICC meeting will discuss ``Diabetes: A1c/Questions/
Diagnosis.''
    Any member of the public interested in presenting oral comments to 
the Committee should notify the Contact Person listed on this notice at 
least 10 days in advance of the meeting. Interested individuals and 
representatives or organizations should submit a letter of intent, a 
brief description of the organization represented, and a written copy 
of their oral presentation in advance of the meeting. Only one 
representative of an organization will be allowed to present oral 
comments and presentations will be limited to a maximum of five 
minutes. Both printed and electronic copies are requested for the 
record. In addition, any interested person may file written comments 
with the Committee by forwarding their statement to the Contact Person 
listed on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person. Because of time constraints for 
the meeting, oral comments will be allowed on a first come, first serve 
basis.
    A registration link and information about the DMICC meeting will be 
available on the DMICC Web site:  http://www.diabetescommittee.gov. 
Members of the public who would like to receive e-mail notification 
about future DMICC meetings could register on a listserv available on 
the same Web site.
    For further information concerning this meeting contact Dr. Sanford 
Garfield, Executive Secretary of the Diabetes Mellitus Interagency 
Coordinating Committee, National Institute of Diabetes and Digestive 
and Kidney Diseases, 6707 Democracy Boulevard, Room 654, MSC 5460, 
Bethesda, MD 20892-5460, Telephone: 301-594-8803 FAX: 301-402-6271, E-
mail: <a href="/cdn-cgi/l/email-protection#f6929b9f9595b69b979f9ad8989f9ed8919980"><span class="__cf_email__" data-cfemail="c2a6afaba1a182afa3abaeecacabaaeca5adb4">[email protected]</span></a>.

    Dated: February 14, 2011.
Sanford Garfield,
Executive Secretary, DMICC, Division of Diabetes, Endocrinology and 
Metabolic Diseases, NIDDK, National Institutes of Health.
[FR Doc. 2011-3765 Filed 2-17-11; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>